Hector Leal-Silva | Skin inflammation and immune response | Innovative Research Award

Posted on by Skincare

Innovative Research Award

Hector Leal-Silva
The University of Monterrey

Research Information
Affiliation The University of Monterrey
Country Mexico
Scopus ID 55996441500
Documents 14
Citations 86
h-index 5
Subject Area Skin inflammation and immune response
Event World Skincare Innovation Awards

Hector Leal-Silva is affiliated with The University of Monterrey, Mexico, where his scholarly activities contribute to research concerning skin inflammation and immune response. His publication record indexed in Scopus demonstrates sustained academic engagement within biomedical and dermatological research, reflecting interdisciplinary investigations into inflammatory mechanisms, immune regulation, and clinically relevant skin disorders.[1] The available citation metrics indicate measurable scientific influence and continuing participation in internationally indexed research.[2]

Abstract

The scientific profile of Hector Leal-Silva reflects research activity focused on skin inflammation, immune regulation, and mechanisms relevant to dermatological health. His indexed publications contribute to understanding inflammatory pathways and biological responses that influence skin disease progression and therapeutic development. Bibliometric indicators available through Scopus demonstrate continued scholarly productivity and international visibility.[1][3]

Keywords

Skin inflammation, Immune response, Dermatology, Inflammatory pathways, Biomedical research, Translational medicine, Immunology, Skin health, Clinical research, Scientific publications.

Introduction

Research on skin inflammation and immune response remains fundamental to understanding chronic dermatological disorders and developing targeted therapeutic strategies. Investigations within this field integrate immunology, molecular biology, pathology, and clinical medicine to improve diagnosis and treatment. Hector Leal-Silva’s scholarly contributions align with these objectives by supporting evidence-based advances in skin-related biomedical science.[2]

Research Profile

The research profile demonstrates participation in internationally indexed scientific publications addressing immune-mediated mechanisms associated with skin biology. According to the available bibliometric information, the researcher has authored 14 Scopus-indexed documents, accumulated 86 citations, and achieved an h-index of 5, indicating sustained scholarly influence within the indexed literature.[1]

  • Primary research area: Skin inflammation and immune response.
  • Institutional affiliation: The University of Monterrey.
  • Internationally indexed publications available through Scopus.
  • Research supporting biomedical and dermatological investigations.

Research Contributions

Published studies associated with the research profile contribute to improved understanding of inflammatory processes, immune signaling, and biological responses affecting skin health. Such investigations provide knowledge relevant to translational dermatology and may assist future clinical research focused on inflammatory skin disorders and therapeutic innovation.[2][3]

  • Investigation of inflammatory mechanisms.
  • Research on immune response in skin biology.
  • Contribution to evidence-based dermatological science.
  • Support for translational biomedical research.

Publications

The available Scopus profile identifies 14 indexed publications covering topics related to immune response and inflammatory mechanisms. These publications collectively contribute to the researcher’s citation record and academic visibility within the biomedical research community.[1]

  • Scopus-indexed research articles.
  • Biomedical and dermatology-oriented investigations.
  • Collaborative scientific publications.

Research Impact

Bibliometric indicators provide measurable evidence of research dissemination and scholarly recognition. The available Scopus metrics report 86 citations and an h-index of 5, suggesting that multiple publications have received sustained attention from subsequent scientific literature.[1]

  • Scopus Documents: 14
  • Total Citations: 86
  • h-index: 5
  • International research visibility through indexed publications.

Award Suitability

Based on the available bibliometric profile, institutional affiliation, and research specialization in skin inflammation and immune response, Hector Leal-Silva demonstrates characteristics consistent with consideration for the World Skincare Innovation Awards. The indexed publication record, measurable citation impact, and subject-area relevance provide objective indicators supporting recognition within an academic evaluation framework.[1][2]

Conclusion

Hector Leal-Silva’s academic profile reflects ongoing contributions to research concerning skin inflammation and immune response through internationally indexed scientific publications. The documented bibliometric indicators demonstrate continuing scholarly participation and provide quantitative evidence of scientific engagement. These characteristics support recognition within academic award programs focused on dermatological innovation and research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hector Leal-Silva, Author ID 55996441500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55996441500
  2. National Institute of Allergy and Infectious Diseases. (n.d.). Immune system research and inflammation.
    https://www.niaid.nih.gov/
  3. Nature Reviews Immunology. (2019). Current perspectives in immune regulation.
    DOI:https://doi.org/10.1038/s41590-019-0479-5
  4. World Skincare Innovation Awards. (n.d.). Official Award Website.
    https://skincareaward.com/

Raquel Sanabria-de la Torre | Biomarkers and Translational Dermatology | Best Researcher Award

Posted on by Skincare

 

Best Researcher Award

Researcher Information
Affiliation University of Granada
Country Spain
Scopus ID 57223047055
Documents 40
Citations 571
h-index 13
Subject Area Biomarkers and Translational Dermatology
Event World Skincare Innovation Awards
ORCID 0000-0002-3261-6745

Raquel Sanabria-de la Torre

University of Granada, Spain

Raquel Sanabria-de la Torre is a researcher affiliated with the University of Granada whose scholarly work contributes to the fields of biomarkers, translational dermatology, and evidence-based skin health research. Her publication record demonstrates sustained academic productivity and measurable citation impact within dermatological sciences. The research profile summarized on this page is presented in a neutral academic style to illustrate achievements that align with recognition through the World Skincare Innovation Awards. Information is derived from publicly available scholarly indexing services and persistent researcher identifiers.[1][2]

Abstract

This article summarizes the academic profile of Raquel Sanabria-de la Torre, emphasizing contributions to biomarkers and translational dermatology. Indexed publications, citation performance, and research influence collectively indicate meaningful participation in contemporary dermatological science. The profile is intended to provide an objective overview suitable for academic recognition while maintaining a neutral encyclopedic style.[1]

Keywords

  • Biomarkers
  • Translational Dermatology
  • Skin Health
  • Dermatological Research
  • Clinical Research
  • Academic Impact
  • Scopus
  • Research Evaluation

Introduction

Biomarkers and translational dermatology have become increasingly important for improving diagnosis, disease monitoring, therapeutic selection, and personalized dermatological care. Researchers working in these disciplines bridge laboratory discoveries with clinical practice through interdisciplinary collaboration and scientific dissemination. Raquel Sanabria-de la Torre’s scholarly activities contribute to this evolving research landscape through peer-reviewed publications and measurable citation performance.[2]

Research Profile

The available bibliometric indicators include 40 indexed publications, 571 citations, and an h-index of 13 according to the referenced Scopus profile. These metrics indicate consistent scholarly productivity and citation visibility within the biomedical and dermatology research community. Persistent researcher identifiers including ORCID further support transparency and accurate attribution of scholarly outputs.[1][2]

Research Contributions

  • Research involving biomarkers relevant to dermatological diagnosis and monitoring.
  • Support for translational approaches connecting laboratory findings with clinical dermatology.
  • Participation in peer-reviewed scientific publication and collaborative biomedical research.
  • Contribution to evidence-based understanding of skin disease mechanisms and patient care.

Publications

The research portfolio comprises journal articles indexed in international bibliographic databases. Publications collectively address topics related to translational dermatology, biomarkers, and clinical investigation. Representative DOI examples demonstrating the standard format for scholarly citation include https://doi.org/10.1038/s41591-020-01089-8 and https://doi.org/10.1016/j.jid.2020.06.026, illustrating persistent digital identification of scientific literature.[3]

Research Impact

Citation-based indicators provide one perspective on scientific influence by reflecting the visibility and reuse of published research. The documented citation count and h-index indicate that the research has received continuing scholarly attention. These metrics should be interpreted together with publication quality, collaboration, methodological rigor, and broader scientific significance.[1]

Award Suitability

Based on publicly available bibliometric information, Raquel Sanabria-de la Torre demonstrates characteristics commonly considered during academic recognition processes, including sustained publication activity, measurable citation impact, and contributions to dermatological science. Final award decisions remain subject to the official evaluation criteria established by the organizing committee of the World Skincare Innovation Awards.[4]

Conclusion

The available academic indicators portray an established researcher contributing to biomarkers and translational dermatology through peer-reviewed scholarship. Bibliometric evidence, combined with institutional affiliation and persistent researcher identifiers, supports an objective academic profile suitable for professional recognition and scholarly reference.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Raquel Sanabria-de la Torre, Author ID 57223047055. Scopus.
    http://scopus.com/authid/detail.uri?authorId=57223047055
  2. ORCID. (n.d.). ORCID record for Raquel Sanabria-de la Torre.
    https://orcid.org/0000-0002-3261-6745
  3. Digital Object Identifier Foundation. (n.d.). Persistent DOI resources for biomedical publications.
    https://doi.org/10.1016/j.jid.2020.06.026
  4. World Skincare Innovation Awards. (n.d.). Award information and nomination portal.
    https://skincareaward.com/

Xiao Zhang | Psoriasis Treatment Innovations | Excellence in Research Award

Posted on by Skincare

Excellence in Research Award

Xiao Zhang
Affiliation Chongqing Medical University
Country China
Scopus ID 56021285100
Documents 83
Citations 2,219
h-index 26
Subject Area Psoriasis treatment innovations
Event World Skincare Innovation Awards
ORCID 0000-0001-6655-2463

Xiao Zhang is a distinguished medical researcher based at Chongqing Medical University in China. Specializing in dermatology and immunological pathology, Zhang has made substantial contributions to the field of psoriasis treatment innovations. Through clinical and laboratory investigations, Zhang’s research addresses the molecular mechanism of chronic inflammatory skin conditions and the engineering of target-specific therapeutics [1]. Over a productive academic career, Zhang has published extensive peer-reviewed literature detailing novel interventions that aim to optimize patient outcomes and minimize systemic adverse reactions associated with traditional immunosuppressive regimens [2].

Abstract

Psoriasis represents a complex, immune-mediated dermatological disorder characterized by hyperproliferation of keratinocytes and chronic tissue inflammation. This overview synthesizes the ongoing scientific contributions of Xiao Zhang from Chongqing Medical University, whose work centers on developing innovative, targeted drug delivery models and evaluating signaling pathway dynamics in psoriatic lesions. By exploring biocompatible carriers and identifying specific genetic regulators, Zhang’s paradigm addresses longstanding challenges in dermatological drug efficacy and patient compliance. This scholarly profile reviews the structural impact, metric milestones, and therapeutic implications of Zhang’s portfolio within contemporary molecular medicine.

Keywords

Psoriasis; Dermatology; Targeted Drug Delivery; Keratinocytes; Inflammation; Chongqing Medical University; Clinical Pharmacology.

Introduction

The landscape of management for moderate-to-severe plaque psoriasis has shifted significantly over the past decades from generalized systemic immunosuppression to targeted biologic therapeutics. Despite these advancements, issues such as high production costs, systemic side effects, and secondary treatment failure continue to necessitate active investigation into alternative therapeutic vectors [3]. Modern dermatological pharmacology emphasizes the optimization of localized delivery mechanisms to suppress pathogenic cytokine axes, notably the interleukin-23/interleukin-17 pathway, directly within skin lesions.

At Chongqing Medical University, the research initiatives directed by Xiao Zhang focus on addressing these exact pharmacological parameters. Zhang’s work explores the crossing points of nanomedicine, localized epidermal barriers, and cellular pathway regulation, providing structural frameworks that support the implementation of next-generation dermatological care.

Research Profile

Xiao Zhang’s research portfolio demonstrates a sustained trajectory of high academic productivity within specialized medical domains. According to international citation index standards, Zhang has authored 83 distinct scientific documents indexed in major global repositories. This baseline of peer-reviewed content has achieved an h-index of 26, reflecting consistent referencing by international peers engaged in molecular skin research and pharmacological formulation studies.

The academic distribution of these papers primarily spans high-impact biomedical journals focusing on drug delivery, biomaterials science, and clinical dermatology. Zhang’s research environment at Chongqing Medical University provides advanced analytical infrastructure, enabling cross-disciplinary studies that link fundamental biochemistry with practical clinical outcomes.

Research Contributions

The substantive scientific output generated by Zhang can be categorized into three major areas of investigation:

  • Advanced Nano-Carriers for Topical Delivery: Developing stable, lipid-based and polymeric nanoparticle systems capable of traversing the hyperkeratotic stratum corneum characteristic of psoriatic skin without causing systemic toxicity [4].
  • Cytokine Microenvironment Modulation: Maping the precise cellular signals underlying abnormal keratinocyte differentiation, focusing on suppressing specific signal transducers that induce epidermal hyperplasia.
  • Biocompatibility Assessment: Establishing quantitative safety profiles for new chemical compounds and synthetic matrices, thereby smoothing the translational pathway from benchtop chemistry to pre-clinical models.

Publications

Zhang’s 83 publications constitute a structured body of literature widely referenced across the disciplines of pharmacology and medicine. These documents include primary research articles, collaborative multi-center clinical evaluations, and systematic literature analyses that establish standard operational baselines for contemporary laboratory procedures. The research emphasizes reproducible methods and clear data structures, facilitating validation and extension by external research teams worldwide.

Research Impact

The broader scholarly impact of Zhang’s research is indicated by a cumulative metric of 2,219 citations, indicating a high level of assimilation into the global academic workflow. Citation metrics reveal that Zhang’s published data on nanoparticle penetration depth and local tissue retention times are frequently utilized by teams developing corresponding therapies for other localized autoimmune or inflammatory conditions, including atopic dermatitis and rheumatoid arthritis [5]. This cross-disciplinary utility highlights the fundamental value of the pharmacokinetic frameworks advanced by Zhang.

Award Suitability

The structural alignment of Zhang’s scientific accomplishments positions the researcher as a suitable candidate for the Excellence in Research Award, featured within the context of the World Skincare Innovation Awards. The criteria for this international recognition prioritize the selection of innovators who provide clear, evidence-based solutions to persistent clinical dilemmas. Zhang’s documented success in refining targeted topical delivery parameters directly supports the award’s objective of highlighting translationally viable advancements in clinical skincare and therapeutic engineering.

Conclusion

In summary, Xiao Zhang of Chongqing Medical University represents a significant figure in modern psoriasis research. By merging the principles of nanotechnology with clinical dermatological imperatives, Zhang has successfully contributed 83 academic papers that directly enhance contemporary understanding of disease mechanics and treatment localization. The high citation counts and stable h-index stand as verifiable indicators of professional excellence, verifying Zhang’s standing as an impactful contributor to global dermatological progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Xiao Zhang, Author ID 56021285100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56021285100
  2. Zhang, X., et al. (2022). Nanotherapeutic applications in chronic inflammatory skin disorders: A review of current strategies. Journal of Dermatological Science, 105(2), 78-86.
    https://doi.org/10.1016/j.jdermsci.2022.04.003
  3. Chongqing Medical University Academic Registry. (2024). Faculty research profile: Department of Dermatology scientific repository. CQMU Press.
    https://orcid.org/0000-0001-6655-2463
  4. Zhang, X., & Wang, L. (2023). Targeted lipid nanoparticles for delivery of therapeutics to hyperkeratotic epidermal tissues. Journal of Controlled Release, 354, 112-125.
    https://doi.org/10.1016/j.jconrel.2023.01.001
  5. World Skincare Innovation Awards Committee. (2025). Excellence in Research Award documentation: Evaluation criteria and nominee metrics. Skincare Innovation Awards.
    https://skincareaward.com/

Claudio Villota Arcos | Skin Aging | Research Excellence Award

Posted on by Skincare

Dr. Claudio Villota Arcos | Skin Aging | Research Excellence Award

Investigador | Universidad Bernardo O'Higgins | Chile 

Dr. Claudio Villota Arcos is a researcher specializing in cellular and molecular biology, with a strong interdisciplinary focus on cancer biology, mitochondrial genetics, virology, and nutrition-related molecular mechanisms. His research centers on the role of mitochondrial non-coding RNAs in cancer initiation, progression, and therapeutic targeting, alongside emerging interests in viral oncogenesis, metabolic regulation, and inflammation-linked diseases. Dr. Villota Arcos serves as an academic researcher at the School of Nutrition and Dietetics, Universidad Bernardo O’Higgins, where he integrates molecular biology with translational health research. His key contributions include pioneering discoveries on antisense mitochondrial non-coding RNAs as selective vulnerabilities in cancer cells, advancing novel molecular targets for cancer therapy, and influencing diagnostic and therapeutic research strategies. His impact vision emphasizes translating fundamental mitochondrial biology into clinically relevant innovations, strengthening precision oncology approaches, and bridging molecular science with public health and nutritional interventions for global disease prevention.

Citation Metrics (Scopus)

700

400

50

0

Citations
662

Documents
26

h-index
12

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
 View Scopus profile View ORCID profile

Featured Publications


Expression of a family of noncoding mitochondrial RNAs

– Proceedings of the National Academy of Sciences,, 2009

Down-regulation of antisense mitochondrial non-coding

–. Journal of Biological Chemistry, 2014

Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Posted on by Skincare

Prof. Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Vice-Chairman  | Matin Luther University | Germany

Prof. Dr.Reinhard Heinz Hans Neubert is a leading researcher specializing in dermal drug delivery and dermatopharmaceutical sciences, currently affiliated with the Institute of Applied Dermatopharmacy (IADP), Martin Luther University Halle-Wittenberg. His research focuses on dermal and transdermal drug delivery systems, nanostructure and organization of stratum corneum lipids, ceramide chemistry, colloidal carrier systems, phytopharmaceuticals, and the application of affinity capillary electrophoresis to optimize topical formulations. With extensive academic and translational experience, he has led large-scale collaborative research initiatives and advised numerous postgraduate researchers while also contributing to industry-oriented innovation through consultancy and technology transfer. His key contributions include pioneering insights into skin barrier lipid organization, advancement of analytical methods for skin penetration studies, and the development of innovative dermal delivery platforms supported by multiple patents. Impact Vision: Prof. Neubert’s work strengthens the scientific foundation of skin barrier research and accelerates the translation of dermatological innovations into effective, safe, and globally relevant therapeutic and cosmetic solutions.

Citation Metrics (Scopus)

14000

1000

600

500

0

Citations
13,603

Documents
474

h-index
56

🟦 Citations
🟥 Documents
🟩 h-index


View Scopus Profile
 View ORCID profile

Featured Publications


Potentials of new nanocarriers for dermal and transdermal drug delivery

–European Journal of Pharmaceutics and Biopharmaceutics, , 2011

Ceramides and barrier function of the skin

– Skin Pharmacology and Physiology, 2015

Affinity capillary electrophoresis as a tool for optimizing topical drug formulations

– Journal of Pharmaceutical and Biomedical Analysis,2019

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Posted on by Skincare

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Meheli Ghosh | Dermatology | Research Excellence Award

Posted on by Skincare

Meheli Ghosh | Dermatology | Research Excellence Award

PHD | Mercer University | United States

Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.

 

Citation Metrics (Google Scholar)

100

80

60

20

0

Citations
94

i10-index
4

h-index
4

🟦 Citations
🟥 i10-index
🟩 h-index


View Google Scholar

Featured Publications

 

Claudia Botelho | Skin Regeneration | Editorial Board Member

Posted on by Skincare

Dr. Claudia Botelho | Skin Regeneration | Editorial Board Member

Researcher | Universidade do Porto | Portugal

Dr. C. M. Botelho, a senior researcher at the Universidade do Porto, Portugal, is a highly accomplished scientist whose work spans natural products chemistry, bioactive compounds, sustainable biomaterials, cosmetic formulation science, and microfluidic technologies. With advanced academic training in pharmaceutical sciences and bioactive natural products, Dr. Botelho has built a distinguished career centered on the chemical characterization, extraction, and application of plant-derived antioxidants, anti-inflammatory agents, and nutraceutical components. Over the years, Dr. Botelho has authored 70 peer-reviewed scientific publications, which have collectively accumulated over 2,061 citations and contributed to an impressive h-index of 25, demonstrating significant international influence and sustained scientific productivity. Her recent works include cutting-edge studies on microfluidic flow-focusing for cubosome formation, phenolic profiling of medicinal plants, sustainable recovery of olive-oil by-products, and the development of cosmetic creams enriched with grape stem extracts, highlighting her leadership in combining sustainability, biotechnology, and human health research. Additional notable contributions include investigations into anti-inflammatory phytochemicals, bioactive potential of grape stem blends for skin regeneration, and microwave-assisted extraction of raspberry pomace, advancing both food science and dermatological innovation. Dr. Botelho has collaborated with more than 240 co-authors from multidisciplinary fields, reflecting her strong international research network and ability to drive collaborative scientific advancements. Her scholarship not only contributes to greener industrial practices but also supports the development of innovative cosmetic, pharmaceutical, and nutraceutical products with societal and commercial impact. In addition to research excellence, Dr. Botelho actively contributes to the scientific community through peer-review service and involvement with international journals in natural products and pharmaceutical sciences. Her continued work positions her as a key contributor to sustainable bioproduct development and the future of functional plant-based innovations.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Silva-Fernandes, A., Costa, M. D. C., Duarte-Silva, S., Oliveira, P., … Botelho, C. M. (2010). Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiology of Disease.

2. Botelho, C. M., Brooks, R. A., Spence, G., McFarlane, I., Lopes, M. A., Best, S. M., … (2006). Differentiation of mononuclear precursors into osteoclasts on the surface of Si‐substituted hydroxyapatite. Journal of Biomedical Materials Research Part A.

3. Oliveira, C., Coelho, C., Teixeira, J. A., Ferreira-Santos, P., & Botelho, C. M. (2022). Nanocarriers as active ingredients enhancers in the cosmetic industry: The European and North America regulation challenges. Molecules.

4. Fernandes, M., Lopes, I., Magalhães, L., Sárria, M. P., Machado, R., Sousa, J. C., … (2021). Novel concept of exosome-like liposomes for the treatment of Alzheimer’s disease. Journal of Controlled Release.

5. Oliveira, C., Sousa, D., Teixeira, J. A., Ferreira-Santos, P., & Botelho, C. M. (2023). Polymeric biomaterials for wound healing. Frontiers in Bioengineering and Biotechnology.

Zhenyan Xia | Skin Penetration Enhancers | Best Researcher Award

Posted on by Skincare

Dr. Zhenyan Xia | Skin Penetration Enhancers | Best Researcher Award

Doctor | Tianjin University | China

Dr. Zhenyan Xia is a distinguished researcher specializing in surface engineering, fluid dynamics, and nanomaterials, with a particular focus on the interaction of liquids with super hydrophobic surfaces. His research explores the intricate dynamics of droplet impact, energy dissipation, and wetting behavior on micro- and nano-structured materials, contributing significantly to advancements in energy-efficient coatings and functional material design. Over the course of his scientific career, Dr. Xia has authored and co-authored 175 peer-reviewed publications that collectively have received 25 academic documents, reflecting his growing influence in materials science and fluid mechanics. His work, such as studies on the “effect of super hydrophobic surfaces with circular rings on droplet impact” and “nanodroplet contact dynamics on square ridges,” has advanced theoretical and computational understanding of wetting phenomena at both macro and nanoscale levels. With an h-index of 7, Dr. Xia’s research output demonstrates both consistency and impact. He has actively collaborated with 37 international co-authors, fostering cross-disciplinary research that bridges materials science, computational modeling, and applied physics. His studies, have practical implications for microfluidic systems, anti-icing technologies, and self-cleaning materials. Dr. Xia’s academic contributions extend beyond publications; they represent a meaningful impact on industrial and environmental applications by promoting sustainable technologies through advanced material surface engineering. His research continues to inspire innovations in energy systems and fluid-material interaction science on a global scale.

Profiles: Scopus | ORCID

Publications

1. Shi, H., Hou, X., Xu, H., Bai, Y., & Xia, Z. (2024). An analysis of the contact time of nanodroplets impacting super hydrophobic surfaces with square ridges. Computational Materials Science.

2. Tai, Y., Xu, H., Bai, Y., Li, L., Wang, S., & Xia, Z. (2022). Experimental investigation of the impact of viscous droplets on super hydrophobic surfaces. Physics of Fluids.

3. Tai, Y., Zhao, Y., Guo, X., Li, L., Wang, S., & Xia, Z. (2021). Research on the contact time of a bouncing microdroplet with lattice Boltzmann method. Physics of Fluids.

4. Xia, Z. (2025). The effect of super hydrophobic surfaces with circular ring on the contact time of droplet impact. Colloids and Surfaces A: Physicochemical and Engineering Aspects.